Clinical trial
NK Cell Deregulation in HBV Patients
NCT03761875 is registered in ClinicalTrials.gov with University Hospital, Limoges as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- NK Cell Deregulation in HBV Patients
- Lead sponsor
- University Hospital, Limoges
- Phase
- Not applicable
- Overall status
- Active, not recruiting
- Start date
- December 11, 2018
- Completion date
- November 11, 2026
- Enrollment
- 80 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hepatitis b virus